Innovel Medical: Bridging Procurement and Clinical Risks in Airway Securement

Innovel Medical, a company headquartered in London that specializes in developing medical technologies with a strong clinical emphasis and backed by Pentland Medical funding, offers valuable insights into how choices made during procurement processes can significantly affect patient outcomes related

Innovel Medical, a company headquartered in London that specializes in developing medical technologies with a strong clinical emphasis and backed by Pentland Medical funding, offers valuable insights into how choices made during procurement processes can significantly affect patient outcomes related to airway safety. This perspective gains even greater importance in scenarios where decisions driven by cost savings overshadow the use of specialized securement devices crafted specifically to enhance patient protection, prevent infections, and ensure the steadfast positioning of tubes.

Stewart Munro, who serves as the Managing Director at Innovel, emphasizes that in environments such as operating theaters and intensive care units, the practice of securing airways plays a crucial role in patient management but frequently does not garner the attention it deserves. He points out that healthcare professionals are well aware of its significance in preserving tube stability throughout periods of anesthesia and mechanical ventilation, yet the specific techniques employed in real-world settings often differ widely from one practitioner to another.

Recent research increasingly validates the consequences stemming from this inconsistency. Data from a comprehensive study indicates that unplanned extubation continues to represent a quantifiable and ongoing challenge to patient safety, despite the proven effectiveness of organized airway protection initiatives in lowering its occurrence rates. Munro interprets these results as highlighting a substantial potential for establishing uniformity in airway handling procedures, especially concerning the selection and implementation of securement devices.

In various medical fields, practices naturally progress as new evidence emerges, but airway securement has historically depended on techniques and materials that were not initially engineered for this precise purpose. Munro advocates for a fresh examination of these longstanding habits through a more deliberate and focused approach. He firmly maintains that incidents of unplanned extubation are avoidable, promoting the adoption of uniform securement strategies bolstered by dependable equipment and established guidelines.

In everyday clinical environments, Munro highlights several issues that arise when relying on securement methods not tailored for airway use. Healthcare providers might experience inconsistencies in how adhesives perform, which can compromise the stability of tubes during procedures that involve patient movement or extended positioning requirements. The condition of the skin also emerges as a key concern, especially for vulnerable groups like children and elderly individuals, where the frequent application and removal of everyday tapes can damage the skin's natural protective layer. Although these matters are typically addressed directly at the patient's bedside, they collectively contribute to wider implications for both clinical workflows and operational efficiency.

Further evidence from investigations into ventilator-associated pneumonia underscores the critical nature of reliable airway securement. Guidance on monitoring pneumonia points to the contributions of tube displacement and subtle aspiration events in allowing bacteria to reach the lower respiratory tract. An extensive meta-analysis involving over 16,000 participants revealed that the need for re-intubation elevates the likelihood of developing ventilator-associated pneumonia by more than five times. Munro emphasizes that these observations strengthen the vital link between maintaining airway stability and minimizing infection risks, thereby highlighting the merits of securement techniques that deliver reliable performance over the entire course of treatment.

Munro provides further commentary on the interplay between these practical clinical challenges and the strategies employed in procurement. He notes that when choices are predominantly influenced by the lowest unit price, it becomes challenging to fully evaluate the subsequent clinical ramifications that ensue. By broadening the evaluation criteria to encompass the overall effects on patient care, a more equitable assessment becomes possible. This standpoint mirrors an expanding dialogue among healthcare executives and purchasing professionals regarding the synchronization of acquisition strategies with overarching objectives for patient safety and operational effectiveness.

In response to these observations, Innovel has introduced LeaFix, an innovative device engineered exclusively for securing endotracheal tubes. Designed with equal priority on achieving robust stability and ensuring compatibility with skin, LeaFix features an advanced adhesive structure that evenly spreads pressure across key anatomical fixation sites, thereby promoting reliable tube placement. Its certification under the European Union's Medical Device Regulation demonstrates compliance with rigorous quality and safety benchmarks, offering healthcare teams confidence in its reliability and enabling Innovel to gather practical clinical data for ongoing enhancements.

More than just its engineering specifications, LeaFix signifies an increasing acknowledgment of airway securement as a specialized domain within healthcare delivery. As Munro observes, in numerous other aspects of medical care, dedicated devices have gradually been developed as knowledge of specific clinical demands and expected performance standards has deepened over time.

Complementing this focus, Innovel's extended range of products includes integrated offerings such as combined packaging for eye protection and airway securement tools, aligning with their commitment to addressing interconnected requirements throughout the airway care continuum. Additionally, Innovel has developed the Vacuderm, a sophisticated tourniquet system intended not only to detect hard-to-see veins but also to streamline the cannulation process for improved procedural success.

Discussions surrounding airway securement are gaining momentum in professional gatherings and training programs. Innovel recently backed a webinar where leading clinicians discussed airway hazards and advancing best practices. Munro points out that such venues play a pivotal role in heightening awareness and encouraging meaningful exchanges among frontline clinicians, facility administrators, and regulatory influencers.

As healthcare institutions work to optimize their patient safety protocols, airway securement offers a promising avenue for harmonizing clinical expertise, compliance with regulations, and procurement methodologies. Munro concludes that advancement typically starts by identifying practices that have lingered unchanged for extended periods. Subsequently, substantive enhancements can be realized via cooperative efforts and innovative design principles.

A promising trajectory forward involves a holistic integration in decision-making processes, whereby procurement specialists weigh not only upfront expenses but also factors like device efficacy in clinical use, enhancements to patient comfort, and enduring influences on system-wide performance. Through championing the implementation of specialized, compliant devices, medical facilities can foster heightened uniformity in airway procedures, ultimately leading to superior patient results in a variety of treatment contexts.

This evolving dialogue emphasizes the need for procurement strategies that transcend mere financial metrics, incorporating comprehensive evaluations of clinical risks such as unplanned extubations, skin injuries, and infection probabilities. By prioritizing purpose-built technologies like LeaFix, healthcare providers can mitigate these risks more effectively, ensuring that airway management aligns seamlessly with evidence-based practices and regulatory expectations.

Munro's insights also touch on the broader implications for training and protocol standardization. As awareness grows through webinars and studies, clinical teams are better equipped to advocate for superior securement solutions during procurement discussions. This shift not only safeguards patients but also optimizes resource allocation by reducing complications that lead to extended hospital stays and additional interventions.

In pediatric and geriatric care, where skin fragility heightens vulnerability, the advantages of anatomically considerate adhesives become even more pronounced. Traditional tapes often exacerbate issues like pressure ulcers or allergic reactions, whereas engineered alternatives distribute forces more gently, preserving skin integrity over multi-day intubations.

From an infection control standpoint, the meta-analysis data on re-intubation and VAP risks serves as a compelling rationale for investing in stable securement. Micro-aspirations from tube shifts can introduce pathogens directly into the lungs, a preventable pathway when stability is assured. Procurement teams evaluating total cost of ownership—factoring in avoided re-intubations, shorter ventilation durations, and lower antibiotic usage—will find purpose-built devices increasingly justifiable.

Innovel's Vacuderm exemplifies their innovative ethos extending beyond airways, addressing venipuncture challenges that parallel securement needs: visibility, gentleness, and efficacy. Such portfolio synergy positions Innovel as a comprehensive partner in critical care technology.

Ultimately, aligning procurement with clinical risk awareness promises a paradigm shift in airway management, where patient-centered design trumps cost-cutting expediency. As Munro articulates, this collaborative evolution holds the key to transforming longstanding conventions into modern, outcome-driven standards.